| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 23,096 | 22,002 | 19,587 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 23,096 | 22,002 | 19,587 | | | Operating Expenses | | Research Development | 82,020 | 155,254 | 166,564 | | Selling General and Administrative | 28,861 | 35,313 | 32,193 | | Non Recurring | 5,419 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (93,204) | (168,565) | (179,170) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,242 | 8,661 | 13,649 | | Earnings Before Interest And Taxes | (87,962) | (159,904) | (165,521) | | Interest Expense | 5,681 | 93 | 523 | | Income Before Tax | (93,643) | (159,997) | (166,044) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (93,643) | (159,997) | (166,044) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (93,643) | (159,997) | (166,044) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($93,643) | ($159,997) | ($166,044) |
|
0.29% Nasdaq 
0.27 (2.01%) 
Income Statement
